United States · Series E startup
2 rounds we have observed, with the 9 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Funding summaryUpdated 26 Oct 2026
$602Mraised across 2 rounds since 2025, from 8 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by Wowtale and 4 others
Reported by Crunchbase News and 2 othersSEC filing: $283M sold, first sale Apr 2025
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Pathos AI's investors include New Enterprise Associates, Vitruvian Partners, Bristol Myers Squibb, WestCap and General Atlantic, and 4 more on record. Bristol Myers Squibb led its latest round.
Pathos AI has raised $602M across 2 rounds since 2025.
Pathos AI's most recent round was a Series E of $237M in Oct 2026, led by Bristol Myers Squibb.
Pathos AI's largest round on record is $365M (Series D), in May 2025, led by Vitruvian Partners.
Pathos AI's first round on record, in May 2025, was backed by Vitruvian Partners, WestCap and New Enterprise Associates and 3 others.
Pathos AI's latest named round is a Series E, in Oct 2026.
Pathos AI is based in the United States.
Vitruvian Partners led the Series D in 2025; Bristol Myers Squibb led the Series E in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
